Aurinia’s loss widened to $14.6 million in Q4 2018
Aurinia Pharmaceuticals (NASDAQ: AUPH/TSX: AUP) reported its fourth quarter and full-year 2018 results after the bell today. The...
Breaking market news, earnings coverage, and in-depth interviews with industry leaders.
Aurinia Pharmaceuticals (NASDAQ: AUPH/TSX: AUP) reported its fourth quarter and full-year 2018 results after the bell today. The...
The marijuana industry’s growth over the past couple of years has been surprising, even from a corporate level....
NF Energy Saving Corp (Nasdaq: BIMI) on Tuesday announced that it plans to buy China-based Boqi Zhengji Pharmacy...
The Michaels Companies Inc. (MIK) reported an 11% drop in earnings for the fourth quarter due to the...
PermRock Royalty Trust (NYSE: PRT) on Tuesday declared a monthly cash distribution. This distribution is to holders of...
Catalyst Pharmaceuticals (Nasdaq: CPRX) reported a loss of $0.14 per share compared to $0.12 loss expected by the...
Amyris (AMRS) reported that it has signed a final definitive agreement for cannabinoid development, licensing and commercialization containing...
On Monday, Apple Inc (AAPL) stock gained 0.7% with the surprise launch of the new 10.5-inch iPad Air...
On Monday, US stocks saw both losses and gains. The impending Fed policy meeting regarding interest hike rates...
Cloud-based solutions provider Smartsheet (SMAR) is scheduled to report fourth-quarter 2019 earnings results on March 19, after the...
Dermira Inc. (DERM) announced positive results from Phase 2b study for treating patients with atopic dermatitis, a condition...
After the slump on weak quarterly results, investors turned positive on Axsome Therapeutics (AXSM) stock, which climbed to...